Anzeige
Erschienen in:
11.10.2022 | Colorectal Cancer
Circulating Tumor DNA, Imaging, and Carcinoembryonic Antigen: Comparison of Surveillance Strategies Among Patients Who Underwent Resection of Colorectal Cancer—A Systematic Review and Meta-analysis
Erschienen in: Annals of Surgical Oncology | Ausgabe 1/2023
Einloggen, um Zugang zu erhaltenAbstract
Background
Almost one-third of colorectal cancer (CRC) patients experience recurrence after resection; nevertheless, follow-up strategies remain controversial. We sought to systematically assess and compare the accuracy of carcinoembryonic antigen (CEA), imaging [positron emission tomography (PET) and computed tomography (CT) scans], and circulating tumor DNA (CtDNA) as surveillance strategies.
Patients and Methods
PubMed, Medline, Embase, Scopus, Cochrane, Web of Science, and CINAHL were systematically searched. The Quality Assessment of Diagnostic Accuracy Studies-2 (QUADAS-2) was used to assess methodological quality. We performed a bivariate random-effects meta-analysis and reported pooled sensitivity, specificity, and diagnostic odds ratio (DOR) values for each surveillance strategy.
Results
Thirty studies were included in the analysis. PET scans had the highest sensitivity to detect recurrence (0.95; 95%CI 0.91–0.97), followed by CT scans (0.77; 95%CI 0.67–0.85). CtDNA positivity had the highest specificity to detect recurrence (0.95; 95%CI 0.91–0.97), followed by increased CEA levels (0.88; 95%CI 0.82–0.92). Furthermore, PET scans had the highest DOR to detect recurrence (DOR 120.7; 95%CI 48.9–297.9) followed by CtDNA (DOR 37.6; 95%CI 20.8–68.0).
Conclusion
PET scans had the highest sensitivity and DOR to detect recurrence, while CtDNA had the highest specificity and second highest DOR. Combinations of traditional cross-sectional/functional imaging and newer platforms such as CtDNA may result in optimized surveillance of patients following resection of CRC.